Vident Investment Advisory’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-24,630	Closed	-$327K	–	737
2023 Q2	$327K	Buy	24,630 +10,476	+74%	+$139K	0.01%	842
2023 Q1	$164K	Buy	+14,154	New	+$164K	0.01%	1127